SCR-LIP-000574 · Claim · machine-readable JSON →

This narrative review of lipedema notes a 'metabolic paradox' and a DEXA leg-fat/total-fat ratio ≥0.384 characterizing the peripheral fat distribution, but the abstract is truncated and does not report specific cancer or metabolic-disease outcome data quantifying protection.

Retired in the claim consolidation (R-CLM-19): its source was judged not to be a finding on any question (e.g. a protocol, a truncated abstract or an off-topic paper). Kept for the record; see the change log below.

Claim at a glance
Type
clinical association
Knowledge state
Emerging
Evidence certainty
very low (GRADE)
Evidence
1 source(s)
Dates
2026-11-17 → 2026-11-17

Structured evidence, machine-compiled — not a verdict.

Auto-compiled by the Layer 1 surveillance loop; not yet human-reviewed. anthropic/claude-opus-4.8 · 2026-11-17

Evidence over time

2026Lipedema: pathophysiological insights and therapeutic strategies — An update for dermatologists (2026) · contextual

Evidence (1)

Context (PECO)

Populationwomen with lipedema (Brazilian prevalence context)
Conditionlipedema
Exposureperipheral/gynoid fat distribution (lipedema)
Outcomemetabolic/cancer risk (not quantified in available abstract)
Scopeauto-ingested from Layer 1 surveillance

Answers these questions

Gaps & caveats

Auto-ingested single source; not yet human-reviewed.

Change log